U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2007
239
Name Type Language
ALEXION
Preferred Name English
ECULIZUMAB
EMA EPAR   INN   MART.   MI   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
H5G11
Code English
H5G1.1VHC+H5G1.1VLC
Code English
ECULIZUMAB [USAN]
Common Name English
ECULIZUMAB [JAN]
Common Name English
ELIZARIA
Brand Name English
eculizumab [INN]
Common Name English
ECULIZUMAB [VANDF]
Common Name English
H5G1-1
Code English
IMMUNOGLOBULIN, ANTI-(HUMAN COMPLEMENT C5 .ALPHA.-CHAIN) (HUMAN-MOUSE MONOCLONAL 5G1.1 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 5G.1.1 LIGHT CHAIN, DIMER
Systematic Name English
ECULIZUMAB [EMA EPAR]
Common Name English
ECULIZUMAB [PURPLE BOOK CDER]
Common Name English
ECULIZUMAB [MI]
Common Name English
ECULIZUMAB [MART.]
Common Name English
SOLIRIS
Brand Name English
Eculizumab [WHO-DD]
Common Name English
5G1.1
Code English
H5G1.1
Code English
Classification Tree Code System Code
NCI_THESAURUS C20401
Created by admin on Wed Apr 02 07:48:16 GMT 2025 , Edited by admin on Wed Apr 02 07:48:16 GMT 2025
FDA ORPHAN DRUG 138800
Created by admin on Wed Apr 02 07:48:16 GMT 2025 , Edited by admin on Wed Apr 02 07:48:16 GMT 2025
FDA ORPHAN DRUG 434214
Created by admin on Wed Apr 02 07:48:16 GMT 2025 , Edited by admin on Wed Apr 02 07:48:16 GMT 2025
FDA ORPHAN DRUG 539416
Created by admin on Wed Apr 02 07:48:16 GMT 2025 , Edited by admin on Wed Apr 02 07:48:16 GMT 2025
NDF-RT N0000175974
Created by admin on Wed Apr 02 07:48:16 GMT 2025 , Edited by admin on Wed Apr 02 07:48:16 GMT 2025
FDA ORPHAN DRUG 398713
Created by admin on Wed Apr 02 07:48:16 GMT 2025 , Edited by admin on Wed Apr 02 07:48:16 GMT 2025
NDF-RT N0000175575
Created by admin on Wed Apr 02 07:48:16 GMT 2025 , Edited by admin on Wed Apr 02 07:48:16 GMT 2025
FDA ORPHAN DRUG 136100
Created by admin on Wed Apr 02 07:48:16 GMT 2025 , Edited by admin on Wed Apr 02 07:48:16 GMT 2025
EMA ASSESSMENT REPORTS SOLIRIS (AUTHORIZED: HEMOGLOBINURIA, PAROXYSMAL)
Created by admin on Wed Apr 02 07:48:16 GMT 2025 , Edited by admin on Wed Apr 02 07:48:16 GMT 2025
FDA ORPHAN DRUG 902222
Created by admin on Wed Apr 02 07:48:16 GMT 2025 , Edited by admin on Wed Apr 02 07:48:16 GMT 2025
FDA ORPHAN DRUG 173203
Created by admin on Wed Apr 02 07:48:16 GMT 2025 , Edited by admin on Wed Apr 02 07:48:16 GMT 2025
WHO-VATC QL04AA25
Created by admin on Wed Apr 02 07:48:16 GMT 2025 , Edited by admin on Wed Apr 02 07:48:16 GMT 2025
FDA ORPHAN DRUG 417213
Created by admin on Wed Apr 02 07:48:16 GMT 2025 , Edited by admin on Wed Apr 02 07:48:16 GMT 2025
FDA ORPHAN DRUG 279509
Created by admin on Wed Apr 02 07:48:16 GMT 2025 , Edited by admin on Wed Apr 02 07:48:16 GMT 2025
WHO-ATC L04AA25
Created by admin on Wed Apr 02 07:48:16 GMT 2025 , Edited by admin on Wed Apr 02 07:48:16 GMT 2025
FDA ORPHAN DRUG 354511
Created by admin on Wed Apr 02 07:48:16 GMT 2025 , Edited by admin on Wed Apr 02 07:48:16 GMT 2025
EU-Orphan Drug EU/3/14/1238
Created by admin on Wed Apr 02 07:48:16 GMT 2025 , Edited by admin on Wed Apr 02 07:48:16 GMT 2025
Code System Code Type Description
INN
8231
Created by admin on Wed Apr 02 07:48:16 GMT 2025 , Edited by admin on Wed Apr 02 07:48:16 GMT 2025
PRIMARY
LACTMED
Eculizumab
Created by admin on Wed Apr 02 07:48:16 GMT 2025 , Edited by admin on Wed Apr 02 07:48:16 GMT 2025
PRIMARY
IUPHAR
6884
Created by admin on Wed Apr 02 07:48:16 GMT 2025 , Edited by admin on Wed Apr 02 07:48:16 GMT 2025
PRIMARY
SMS_ID
100000089131
Created by admin on Wed Apr 02 07:48:16 GMT 2025 , Edited by admin on Wed Apr 02 07:48:16 GMT 2025
PRIMARY
NCI_THESAURUS
C48386
Created by admin on Wed Apr 02 07:48:16 GMT 2025 , Edited by admin on Wed Apr 02 07:48:16 GMT 2025
PRIMARY
CAS
2648435-91-8
Created by admin on Wed Apr 02 07:48:16 GMT 2025 , Edited by admin on Wed Apr 02 07:48:16 GMT 2025
PRIMARY
CAS
219685-50-4
Created by admin on Wed Apr 02 07:48:16 GMT 2025 , Edited by admin on Wed Apr 02 07:48:16 GMT 2025
NO STRUCTURE GIVEN
DAILYMED
A3ULP0F556
Created by admin on Wed Apr 02 07:48:16 GMT 2025 , Edited by admin on Wed Apr 02 07:48:16 GMT 2025
PRIMARY
FDA UNII
A3ULP0F556
Created by admin on Wed Apr 02 07:48:16 GMT 2025 , Edited by admin on Wed Apr 02 07:48:16 GMT 2025
PRIMARY
MESH
C481642
Created by admin on Wed Apr 02 07:48:16 GMT 2025 , Edited by admin on Wed Apr 02 07:48:16 GMT 2025
PRIMARY
DRUG BANK
DB01257
Created by admin on Wed Apr 02 07:48:16 GMT 2025 , Edited by admin on Wed Apr 02 07:48:16 GMT 2025
PRIMARY
CAS
2276801-68-2
Created by admin on Wed Apr 02 07:48:16 GMT 2025 , Edited by admin on Wed Apr 02 07:48:16 GMT 2025
ALTERNATIVE
USAN
LL-70
Created by admin on Wed Apr 02 07:48:16 GMT 2025 , Edited by admin on Wed Apr 02 07:48:16 GMT 2025
PRIMARY
ChEMBL
CHEMBL1201828
Created by admin on Wed Apr 02 07:48:16 GMT 2025 , Edited by admin on Wed Apr 02 07:48:16 GMT 2025
PRIMARY
DRUG CENTRAL
4969
Created by admin on Wed Apr 02 07:48:16 GMT 2025 , Edited by admin on Wed Apr 02 07:48:16 GMT 2025
PRIMARY
WIKIPEDIA
ECULIZUMAB
Created by admin on Wed Apr 02 07:48:16 GMT 2025 , Edited by admin on Wed Apr 02 07:48:16 GMT 2025
PRIMARY
RXCUI
591781
Created by admin on Wed Apr 02 07:48:16 GMT 2025 , Edited by admin on Wed Apr 02 07:48:16 GMT 2025
PRIMARY RxNorm
EVMPD
SUB25187
Created by admin on Wed Apr 02 07:48:16 GMT 2025 , Edited by admin on Wed Apr 02 07:48:16 GMT 2025
PRIMARY
MERCK INDEX
m4823
Created by admin on Wed Apr 02 07:48:16 GMT 2025 , Edited by admin on Wed Apr 02 07:48:16 GMT 2025
PRIMARY Merck Index
ACTIVE MOIETY
ECULIZUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966